Trials involving Multiple Types of Cancer

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(Bayer) NAVIGATE / 20289A Phase 2 Basket Study of the Oral TRK Inhibitor larotrectinib in Subjects with NTRK Fusion-Positive TumorsTozer, Dr RichardOpen to recruitmentNCT02576431
(CCTG) IND.238A Phase II Study of Durvalumab Retreatment in Patients who Discontinued Prior Checkpoint Therapy Due to Immune Related ToxicityEllis, Dr PeterOpen to recruitmentNCT03847649
(HHS) CRUSSHStereotactic body radiotherapy (SBRT) boost following urgent 3D conformal radiotherapy in the treatment of metastatic epidural spinal cord compression (SCC): A phase I feasibility trialSchnarr, Dr KaraOpen to recruitmentNCT03529708
(Astellas) 7465-CL-202 / EV-202 / AST 246014An Open-label, Multi-cohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid TumorsHotte, Dr SebastienOpen to recruitmentNCT04225117
(Bold Therapeutics) BOLD-100-001 / TRIO039A Phase 1b Dose Escalation Study of BOLD-100 in Combination with FOLFOX Chemotherapy in Patients with Advanced Solid TumoursMcWhirter, Dr ElaineOpen to recruitmentNCT04421820
(Tesaro) 4010-01-001 / GARNETA Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1
Monoclonal Antibody, in Patients with Advanced Solid Tumors
Reade, Dr ClareSuspended/On holdNCT02715284
Download PDF